Gain Early Access to Professionals Driving Biotech Commercialization

Engage with clinicians, scientists, and investment professionals at the translation point between science, medicine, and capital.

This biotech enterprise investments program convenes emerging fund managers, analysts, clinicians, scientists, operating and deal professionals at the point of product, enterprise, and capital formation. Sponsorship provides targeted exposure, credibility signaling, and early relationship access. Gain access to germinating products, deals, and funds formation.

Sponsor the Biotech Enterprise Investments course which delivers a practical, deal-driven curriculum designed to equip emerging fund managers, clinicians, analysts, scientists, and deal professionals with the skills to evaluate, structure, and manage investments in early-stage biotech and life-science ventures while gaining visibility into the clinical discovery channel. The course is led by a former Johns Hopkins course director. Below are links to sponsorship tiers providing graduated benefits.

This masterclass sits at the intersection of venture science, translational commercialization, fund strategy, and regulatory readiness—an area where your firm plays a crucial role in the investment ecosystem.

Audience Profile
• Emerging fund managers and GPs
• CRE analysts and associates
• Family office–adjacent professionals
• Clinicians, medical doctors, scientists, Biotech professionals, investors
• Career-stage professionals entering fund formation or research programs

For sponsorship inquiries or invoicing requests, please contact our Sponsorship Desk:

📧 cl@silver-equity.com
☎ +1 (646) 359-4212

We routinely accommodate internal approval timelines and invoice-based sponsorships.

Why Sponsor This Program?

Your sponsorship demonstrates leadership in supporting the next wave of innovation professionals who will engage your services as they launch and grow biotech investment vehicles. Sponsors gain visibility with a highly targeted audience of:

• Emerging biotech fund managers

• Analysts entering the venture, fund admin, and institutional due-diligence space

• Life-science entrepreneurs preparing for investment

• Physicians and scientists transitioning into commercialization strategy

• Family offices exploring biotech allocations

By supporting this initiative, you help strengthen the infrastructure around compliant, well-governed, and institutionally prepared fund formation—creating future clients for your services. You can conveniently sponsor and pay using any of the secured channels below.

Who This Sponsorship Is Designed For

We particularly invite sponsorship from:

• Fund Administrators supporting specialized venture funds

• Fund Attorneys / Deal Lawyers who guide biotech fund formation

• Fund Accountants who handle NAV, audit readiness, & capital accounting

• Custodial Payment & Distribution Providers

• Fund Brokers & Exempt Market Dealers

• Placement Agents & Capital Intermediaries

• Consultants & Providers to Life-Science Investors

Your firm will be recognized as a key infrastructure provider for the emerging biotech investor community.

What Sponsors Receive

Depending on your sponsorship tier, benefits may include:

• Recognition on all sponsor-facing pages and materials

• Feature placement on the course’s resource list for students

• Priority introduction to select participants

• Option to include compliant materials in the course resource packet

• Optional mini-session: “How our firm supports biotech fund managers”

• Early access to pipeline of future courses and events

How Your Sponsorship Helps

Your support allows us to:

• Provide subsidized access to underrepresented founders and analysts

• Deliver high-quality instruction on biotech commercialization and fund design

• Expand the curriculum with case studies, tools, and regulatory modules

• Host quarterly strategy discussions for sponsors and alumni

This is a direct investment in building a better, more informed biotech investment ecosystem.